Cinsebrutinib
Product Specifications
UNSPSC Description
Cinsebrutinib is a Bruton's tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib has the potential for cancer study.
Target Antigen
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cinsebrutinib.html
Solubility
10 mM in DMSO
Smiles
FC1=CC(C(N)=O)=C(NC2=C3CCCCC2)C3=C1[C@H]4CN(CCC4)C(C=C)=O
Molecular Weight
383.46
References & Citations
[1]Coburn, Craig Alan, et al. Preparation of pyridoindolecarboxamides and their analogs as BTK kinase inhibitors. WO2021207549.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156604/Cinsebrutinib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156604/
Clinical Information
No Development Reported
CAS Number
2724962-58-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
17941121 3 x 1.0μg DNA
DEFB119 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details ![Mouse Monoclonal ErbB2/Her2 Antibody (HRB2/282) [DyLight 350]](https://cdn.genprice.uk/genprice/genprice2.png)
NBP3-20131JF525 0.1 mL
Rabbit Monoclonal PRMT5 Antibody (RAB-C136) [Janelia Fluor 525]
Ask
View Details